Cargando…
Editorial: Dendritic cell-primed T cells in anti-tumor immune responses and relevant vaccine strategies
Autores principales: | Leavenworth, Jianmei W., Liu, Xindong, Ma, Yunfeng, Zhu, Yibei, Qi, Chunjian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489217/ https://www.ncbi.nlm.nih.gov/pubmed/36148223 http://dx.doi.org/10.3389/fimmu.2022.1023967 |
Ejemplares similares
-
Editorial: Immune Cell Lineage Reprogramming in Cancer
por: Leavenworth, Jianmei W., et al.
Publicado: (2022) -
Editorial: Macrophage immunity and metabolism in cancer: Novel diagnostic and therapeutic strategies
por: Leavenworth, Jianmei W., et al.
Publicado: (2022) -
Lineage Reprogramming of Effector Regulatory T Cells in Cancer
por: Dixon, Michael L., et al.
Publicado: (2021) -
Therapeutic Use of Dendritic Cells to Promote the Extranodal Priming of Anti-Tumor Immunity
por: Chen, Lu, et al.
Publicado: (2013) -
Contribution of Dysregulated B-Cells and IgE Antibody Responses to Multiple Sclerosis
por: Seals, Malik R., et al.
Publicado: (2022)